Figure 3 | Scientific Reports

Figure 3

From: Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients

Figure 3

Bacterial families in the (A) endotracheal, (B) perineal, and (C) faecal microbiota showing significantly different abundances in the 3GC and TZP groups compared to the control group after 48 h (3GC-third-generation cephalosporins, TZP-piperacillin/tazobactam, control-no β-lactams). Data were obtained using LEfSe analyses between each antibiotic treatment and the control group. The histograms show the linear discriminant analysis (LDA) scores computed for each bacterial family.

Back to article page